|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-3-31
|
|
pubmed:abstractText |
To evaluate the effect of vascular endothelial growth factor (VEGF, one of the most important angiogenetic factors) in renal cell carcinoma (RCC) by analysing many RCCs for the expression of immunohistochemical (IHC) VEGF-staining related to clinicopathological findings and survival.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1464-4096
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
93
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
297-302
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14764126-Adult,
pubmed-meshheading:14764126-Aged,
pubmed-meshheading:14764126-Aged, 80 and over,
pubmed-meshheading:14764126-Carcinoma, Renal Cell,
pubmed-meshheading:14764126-Female,
pubmed-meshheading:14764126-Follow-Up Studies,
pubmed-meshheading:14764126-Humans,
pubmed-meshheading:14764126-Immunohistochemistry,
pubmed-meshheading:14764126-Kidney Neoplasms,
pubmed-meshheading:14764126-Male,
pubmed-meshheading:14764126-Middle Aged,
pubmed-meshheading:14764126-Neoplasm Proteins,
pubmed-meshheading:14764126-Neoplasm Staging,
pubmed-meshheading:14764126-Prognosis,
pubmed-meshheading:14764126-Survival Analysis,
pubmed-meshheading:14764126-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Expression of vascular endothelial growth factor protein in human renal cell carcinoma.
|
|
pubmed:affiliation |
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
